SHINE Closes $80M Series C
SHINE Medical Technologies has closed an $80 million Series C financing round, the company announced recently. “This funding round will help SHINE’s continuing efforts to commercialize vital diagnostic and therapeutic…
Tag Archives: Greg Piefer
NRC to Decide on SHINE Operating License by 2021
The U.S. Nuclear Regulatory Commission (NRC) expects to make a final determination regarding the issuance of an operating license to SHINE Medical Technologies by October 2021, the company announced today….
SHINE Recaps 2019 Achievements
SHINE Medical Technologies recently announced its 2019 year-end report, which included updates on its construction progress, continued investor support, its new therapeutics division and information about commercial and regulatory news….
SHINE Raises $50M
SHINE Medical Technologies announced recently that it closed a $50 million financing round with Oaktree Capital Management. According to a release, the funds will be for the construction of SHINE’s medical…
SHINE, Phoenix Set World Record
SHINE Medical Technologies and Phoenix set a world record for a nuclear fusion reaction in a steady-state system, the strongest of its kind ever produced on Earth, SHINE announced today….
SHINE Adds Paul Ryan to BOD
SHINE Medical Technologies added former House Speaker Paul Ryan to its board of directors, the company announced recently. “Paul is a visionary with a wealth of experience and an expansive…
SHINE Receives $15M Award
SHINE Medical Technologies received a $15 million award from the Department of Energy’s National Nuclear Security Administration (DOE/NNSA), the company announced today. “We are grateful for DOE/NNSA’s award as SHINE continues…
SHINE Files App to Produce Medical Isotopes
SHINE Medical Technologies has filed an application with the U.S. Nuclear Regulatory Commission to produce medical isotopes at its production facility in Janesville, Wis., the company announced today. “Completing our…
SHINE, Phoenix Achieve Milestone
SHINE and Phoenix have completed a 132-hour test of the high-flux Phoenix neutron generator that helps to prove the performance and reliability of Phoenix’s neutron generator technology and SHINE’s medical isotope production process, the companies…
SHINE, IOCB Prague Collaborate
SHINE has entered into an intellectual property license agreement with the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), the company announced today. According to a release,…
